American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Period	ROE
2020-12-31	-18.33%
2021-12-31	-14.23%
2022-12-31	-25.42%
2023-12-31	-145.44%
2024-12-31	-68.29%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMWL	$5.70	+6.74%	0.04M
3
4
5

American Well Corporation Class A (AMWL) Return on Equity (ROE)

ROE & ROA Data

Get American Well Corporation Class A Data in Excel

More AMWL Financial Data